|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1979-4-26
|
|
pubmed:abstractText |
A patient with late onset chronic mucocutaneous candidiasis developed lymphocytic lymphoma. A specific inhibitor of in vitro lymphoproliferative responses to candidal antigen was detected in her serum which persisted following clinical remission of candidiasis after combined amphotericin-B and 5-Fluorocystosine therapy. It is unclear whether the combined therapy was exclusively anticandidal, nonspecific immunostimulant or cytotoxic affecting the underlying incipient lymphoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
101-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:581657-Amphotericin B,
pubmed-meshheading:581657-Antibodies, Fungal,
pubmed-meshheading:581657-Antigens, Fungal,
pubmed-meshheading:581657-Binding, Competitive,
pubmed-meshheading:581657-Candidiasis, Oral,
pubmed-meshheading:581657-Female,
pubmed-meshheading:581657-Flucytosine,
pubmed-meshheading:581657-Humans,
pubmed-meshheading:581657-Immunity,
pubmed-meshheading:581657-Immunosuppression,
pubmed-meshheading:581657-Lymphocyte Activation,
pubmed-meshheading:581657-Lymphoma, Non-Hodgkin,
pubmed-meshheading:581657-Middle Aged
|
|
pubmed:year |
1979
|
|
pubmed:articleTitle |
Late onset chronic mucocutaneous candidiasis with lymphoma and specific serum inhibitory factor.
|
|
pubmed:publicationType |
Journal Article,
In Vitro,
Case Reports
|
